TRPM2
MOLECULAR TARGETtransient receptor potential cation channel subfamily M member 2
TRPM2 (transient receptor potential cation channel subfamily M member 2) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TRPM2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | NAD | 1.61 | 4 |
| 2 | Clotrimazole | 1.61 | 4 |
| 3 | Econazole | 1.61 | 4 |
| 4 | NAD | 1.61 | 4 |
| 5 | NAD | 1.61 | 4 |
| 6 | Cyclic ADP-Ribose | 1.39 | 3 |
| 7 | Arachidonic Acid | 0.69 | 1 |
| 8 | Adenosine Diphosphate Ribose | 0.69 | 1 |
| 9 | Adenosine Monophosphate Adenine nucleotide containing | 0.69 | 1 |
| 10 | Miconazole | 0.69 | 1 |
| 11 | O-Acetyl-ADP-Ribose | 0.69 | 1 |
About TRPM2 as a Drug Target
TRPM2 (transient receptor potential cation channel subfamily M member 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented TRPM2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TRPM2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.